ERBB2 and neoplasm: In the group of 238 patients with high values of one or both proteolytic enzymes, uPA and PAI-1, 65 patients (27%) had HER2-positive tumours and out of the 214 patients with low values of uPA and PAI-1 47 patients (22%) had HER2-positive tumours.